Kristin L. Brill, MD
Kristin L. Brill, MD, has joined the Sidney Kimmel Cancer Center–Jefferson Health (SKCC) in Philadelphia as Enterprise Director of Breast Oncology. Dr. Brill brings expertise in a comprehensive range of services for patients with malignant and benign diseases, including breast-conserving surgery, nipple-sparing mastectomy, preventive mastectomy, reconstruction, accelerated partial breast radiation device placement, and clinical trials for breast cancer.
“I am thrilled to join the SKCC–Jefferson Health team as the Breast Program enterprise leader,” Dr. Brill said. “SKCC has a long tradition of excellence in cancer care, research, and innovation, providing unparalleled cancer treatment in our region and beyond. Our goal is to provide the same high-quality services across multiple Jefferson locations, with the mission of improving lives and cancer outcomes.”
Dr. Brill joins SKCC from Cooper University Health Care, where she was Head of the Division of Breast Surgery and Director of the Janet Knowles Breast Cancer Center at MD Anderson Cancer Center at Cooper and Assistant Professor of Surgery at Cooper Medical School of Rowan University in Camden, New Jersey.
Karen E. Knudsen, MBA, PhD
“[Dr. Brill] is an exceptional breast oncologist who is dedicated to increasing access to the most advanced surgical breast care and will lead Jefferson in developing the next set of technologic breakthroughs for breast cancer patients,” said Karen E. Knudsen, MBA, PhD, Executive Vice President of Oncology Services and Enterprise Director of SKCC.
Dr. Brill received her medical degree from Hahnemann University School of Medicine in Philadelphia. She completed her surgical residency at New York Methodist Hospital in Brooklyn and a breast surgical oncology fellowship at Columbia Presbyterian Medical Center in New York. Her clinical focus includes young women with breast cancer and those at high risk for breast cancer.
Dr. Brill is a Fellow of the American College of Surgeons and a member of ASCO, the American Society of Breast Surgeons, the Society of Surgical Oncology, and the Breastcancer.org advisory board.
